These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 30941966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
    Liu W, Xu H, Ying X, Zhang D, Lai L, Wang L, Tu J, Ji J.
    Med Sci Monit; 2020 Jul 15; 26():e923263. PubMed ID: 32667906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP.
    Zhonghua Yi Xue Za Zhi; 2011 Aug 23; 91(31):2190-4. PubMed ID: 22094036
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Aug 23; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 8. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY, Zhang JL, Wang MQ, Yuan K, Bai YH, Wang Y, Xin HN, Wang ZJ, Liu FY, Duan F, Fu JX.
    Asia Pac J Clin Oncol; 2018 Aug 23; 14(4):300-309. PubMed ID: 29124894
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
    Endo K, Kuroda H, Oikawa T, Okada Y, Fujiwara Y, Abe T, Sato H, Sawara K, Takikawa Y.
    Scand J Gastroenterol; 2018 Dec 02; 53(12):1575-1583. PubMed ID: 30577723
    [Abstract] [Full Text] [Related]

  • 11. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z, Jiao D, Han X, Si G, Li Y, Liu J, Xu Y, Zheng B, Zhang X.
    Cancer Imaging; 2020 Jan 30; 20(1):13. PubMed ID: 32000862
    [Abstract] [Full Text] [Related]

  • 12. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep 30; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 13. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM, Cabrera R, Kapp M, Lazarowicz M, Vogel JD, Toskich BB.
    Curr Probl Diagn Radiol; 2017 Sep 30; 46(6):402-409. PubMed ID: 28392205
    [Abstract] [Full Text] [Related]

  • 14. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB.
    Cardiovasc Intervent Radiol; 2017 Nov 30; 40(11):1748-1755. PubMed ID: 28681222
    [Abstract] [Full Text] [Related]

  • 15. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, Yang Z, Zhang Y, Wang C, Wang Y, Zuo D, Li B, Yuan Y.
    Aliment Pharmacol Ther; 2018 Sep 30; 48(6):671-681. PubMed ID: 30063081
    [Abstract] [Full Text] [Related]

  • 16. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation.
    Zhang XG, Zhang ZL, Hu SY, Wang YL.
    Acta Chir Belg; 2014 Sep 30; 114(1):40-5. PubMed ID: 24720137
    [Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020 Sep 30; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Transarterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma.
    Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA.
    Asian Pac J Cancer Prev; 2015 Sep 30; 16(14):6159-62. PubMed ID: 26320512
    [Abstract] [Full Text] [Related]

  • 19. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
    Zuo TY, Liu FY, Wang MQ, Chen XX.
    Chin Med J (Engl); 2017 Nov 20; 130(22):2666-2673. PubMed ID: 29133753
    [Abstract] [Full Text] [Related]

  • 20. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R, Shen L, Zhao L, Guan Z, Chen Q, Li W.
    Diagn Interv Radiol; 2018 Jul 20; 24(4):219-224. PubMed ID: 29792289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.